Research Paper Volume 16, Issue 2 pp 1484—1495
LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration
Figure 8. Correlation between LRP6 expression and drug sensitivity. Spearman correlation analysis of sunitinib, sorafenib, pazopanib, axtinib and erlotinib IC50 score and LRP6 expression.